(DOC) Healthpeak Properties - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US42250P1030
DOC: Buildings, Hospitals, Labs, Offices, Clinics, Facilities
Healthpeak Properties, Inc., trading under the ticker symbol DOC on the NYSE, stands as a prominent fully integrated real estate investment trust (REIT) and a distinguished member of the S&P 500. Specializing in healthcare real estate, Healthpeak is strategically positioned at the intersection of medical discovery and patient care, owning, operating, and developing properties that cater to this vital sector.
With a market capitalization of approximately $13.89 billion, Healthpeaks portfolio is diversified across high-quality healthcare assets, including life science facilities, medical offices, and senior housing. This diversification underscores the companys resilience and adaptability in navigating the evolving healthcare landscape. The companys inclusion in the S&P 500 reflects its financial stability and market leadership.
From a financial standpoint, Healthpeak presents a intriguing profile for investors. The trailing P/E ratio of 55.17 and a forward P/E of 96.15 suggest that the market anticipates significant future growth, potentially driven by increasing demand for healthcare infrastructure. The price-to-book ratio of 1.68 indicates that investors are valuing the companys assets at a moderate premium. Additionally, the price-to-sales ratio of 5.44 highlights the companys ability to generate revenue from its assets.
For investors and fund managers evaluating Healthpeak, its crucial to consider the broader trends in healthcare real estate. The aging population and advancements in medical research are expected to drive sustained demand for specialized healthcare facilities. Healthpeaks expertise in managing such assets positions it well to capitalize on these trends, making it a noteworthy consideration for portfolios seeking exposure to the healthcare sector.
Additional Sources for DOC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DOC Stock Overview
Market Cap in USD | 14,216m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1987-11-05 |
DOC Stock Ratings
Growth 5y | -0.51% |
Fundamental | 30.0% |
Dividend | 42.5% |
Rel. Strength | 4.7 |
Analysts | 4.15/5 |
Fair Price Momentum | 19.62 USD |
Fair Price DCF | 34.17 USD |
DOC Dividends
Dividend Yield 12m | 5.97% |
Yield on Cost 5y | 6.78% |
Annual Growth 5y | -12.94% |
Payout Consistency | 96.8% |
DOC Growth Ratios
Growth Correlation 3m | 36.4% |
Growth Correlation 12m | 45.8% |
Growth Correlation 5y | -47.2% |
CAGR 5y | 2.57% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | -1.26 |
Alpha | 6.24 |
Beta | 1.118 |
Volatility | 21.05% |
Current Volume | 3458.5k |
Average Volume 20d | 4151.2k |
As of March 31, 2025, the stock is trading at USD 20.19 with a total of 3,458,500 shares traded.
Over the past week, the price has changed by -1.27%, over one month by +0.05%, over three months by +2.62% and over the past year by +15.51%.
Neither. Based on ValueRay Fundamental Analyses, Healthpeak Properties is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 29.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOC as of March 2025 is 19.62. This means that DOC is currently overvalued and has a potential downside of -2.82%.
Healthpeak Properties has received a consensus analysts rating of 4.15. Therefor, it is recommend to buy DOC.
- Strong Buy: 9
- Buy: 5
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DOC Healthpeak Properties will be worth about 21.3 in March 2026. The stock is currently trading at 20.19. This means that the stock has a potential upside of +5.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 24.7 | 22.2% |
Analysts Target Price | 25.3 | 25.4% |
ValueRay Target Price | 21.3 | 5.6% |